IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Artia Global Partners LP

Q4 2022 Holdings

Filed 2023-02-14 | 25 holdings | $262.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Novo-Nordisk A S(NVO)ADR670100205$50.2M371,05519.1%
Lilly ELI & Co(LLY)COM532457108$38.2M104,32814.5%
Argenx SE(ARGX)SPONSORED ADR04016X101$32.3M85,20412.3%
Merck & Co Inc(MRK)COM58933Y105$29.3M264,20011.2%
Karuna Therapeutics IncCOM48576A100$19.5M99,2677.4%
Abbvie Inc(ABBV)COM00287Y109$14.7M90,8215.6%
Moderna Inc(MRNA)COM60770K107$13.4M74,7195.1%
Iveric BIO Inc(OPHTEUR)COM46583P102$10.8M504,6154.1%
Biogen Inc(BIIB)COM09062X103$8.3M30,0003.2%
Seagen Inc(SGENUSD)COM81181C104$6.6M51,1752.5%
Biontech SE(BNTX)SPONSORED ADS09075V102$5.6M37,1082.1%
Neurocrine Biosciences Inc(NBIX)COM64125C109$5.4M45,0002.0%
Astrazeneca PLC(AZN)SPONSORED ADR046353108$5.3M77,7592.0%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$3.8M15,9711.4%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$2.9M28,2171.1%
Thermo Fisher Scientific Inc(TMO)COM883556102$2.8M5,0881.1%
Prometheus Biosciences IncCOM74349U108$2.5M22,3210.9%
Intra-Cellular Therapies Inc(ITCIEUR)COM46116X101$2.2M41,6000.8%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$2.1M7,1140.8%
Moderna IncCallCALL60770K907$1.8M10,0000.7%
Viking Therapeutics Inc(VKTX)COM92686J106$1.2M130,9130.5%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$1.0M39,9510.4%
Waters Corp(WAT)COM941848103$974.6K2,8450.4%
Amylyx Pharmaceuticals Inc(AMLX)COM03237H101$882.5K23,8830.3%
Kymera Therapeutics Inc(KYMR)COM501575104$748.8K30,0000.3%